Literature DB >> 15808429

[Epidemiological and clinical aspects of paediatric HIV infections in Albert-Royer Paediatric Hospital (Dakar, Senegal)].

A Diack MBaye1, H Signaté Sy, N R Diagne Guèye, A Ba, A Sylla, S Diouf, I Diagne, M Sarr, H D Sow.   

Abstract

UNLABELLED: Human Immunodeficiency Virus (HIV) infection prevalence rate is estimated at 1.4% in Senegal, and about 3,000 children could be infected. HIV positive children are followed up since 2000 in Albert Royer Hospital (Dakar, Senegal).
OBJECTIVES: To describe clinical and epidemiological aspects of HIV paediatric infection, and to evaluate the implementation of high active antiretroviral therapy in HIV positive children in our country. POPULATION AND METHODS: Over a period of three years, the medical reports of 98 infected patients have been collected, 96% with HIV 1 infection.
RESULTS: Most of the patients had a maternally transmitted HIV infection (99%). At their enrollment, the median age was 60 months; malnutrition (79%), persistent lymphadenopathy (65%) and skin lesions (64%) were the common clinical manifestations. Thirty-nine percent of the patients were in class C (CDC) and 81% had CD4 cell count< or =25%. Median viral load were 421,852 copies/ml at presentation. Seven infants had a rapid progressive disease with encephalopathy. Thirty-six patients received high active antiretroviral therapy with high observance and good tolerance.
CONCLUSION: This study allowed to define clinical and biological profile of paediatric HIV infection in our country and to update the implementation of high active antiretroviral therapy.

Entities:  

Mesh:

Year:  2005        PMID: 15808429     DOI: 10.1016/j.arcped.2005.01.011

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  7 in total

1.  Growth among HIV-infected children receiving antiretroviral therapy in Dar es Salaam, Tanzania.

Authors:  Ramadhani S Mwiru; Donna Spiegelman; Christopher Duggan; George R Seage; Helen Semu; Guerino Chalamilla; Rodrick Kisenge; Wafaie W Fawzi
Journal:  J Trop Pediatr       Date:  2014-01-06       Impact factor: 1.165

Review 2.  Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries.

Authors:  Elizabeth Peacock-Villada; Barbra A Richardson; Grace C John-Stewart
Journal:  Pediatrics       Date:  2011-01-24       Impact factor: 7.124

3.  Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.

Authors:  Uduak Okomo; Toyin Togun; Francis Oko; Kevin Peterson; John Townend; Ingrid Peterson; Assan Jaye
Journal:  BMC Pediatr       Date:  2012-07-08       Impact factor: 2.125

4.  Antiretroviral treatment program retention among HIV-infected children in the Democratic Republic of Congo.

Authors:  John Ditekemena; Christophe Luhata; William Bonane; Modeste Kiumbu; Antoinette Tshefu; Robert Colebunders; Olivier Koole
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

5.  Baseline demographic, clinical and immunological profiles of HIV-infected children at the Yaounde Gynaeco-Obstetric and Pediatric hospital, Cameroon.

Authors:  Florence Soh Fru; Andreas Chiabi; Séraphin Nguefack; Evelyn Mah; Virginie Takou; Jean Baptiste Bogne; Marie Lando; Pierre-Fernand Tchokoteu; Elie Mbonda
Journal:  Pan Afr Med J       Date:  2014-02-03

6.  Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.

Authors:  Anand Reddi; Sarah C Leeper; Anneke C Grobler; Rosemary Geddes; K Holly France; Gillian L Dorse; Willem J Vlok; Mbali Mntambo; Monty Thomas; Kristy Nixon; Helga L Holst; Quarraisha Abdool Karim; Nigel C Rollins; Hoosen M Coovadia; Janet Giddy
Journal:  BMC Pediatr       Date:  2007-03-17       Impact factor: 2.125

7.  Factors associated with long turnaround time for early infant diagnosis of HIV in Myanmar.

Authors:  Soe Thiha; Hemant Deepak Shewade; Sairu Philip; Thet Ko Aung; Nang Thu Thu Kyaw; Myo Minn Oo; Khine Wut Yee Kyaw; May Wint War; Htun Nyunt Oo
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.